A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Translational Research Laboratory Bookmark and Share

Translational Research Laboratory

The Translational Research Laboratory (TRL) at City of Hope is under the direct supervision of Yen Yun, M.D., Ph.D., Associate Director for Translational Research, City of Hope Comprehensive Cancer Center and, Professor and Chair of the Department ofMolecular Pharmacology.
 
The mission of the Translational Research Laboratory (TRL) Core is to facilitate, implement, and support the needs of basic science researchers, clinical researchers, population researchers and clinical science collaborations. Interactions between basic scientists and clinicians are fostered to ensure the inclusion of scientifically sound correlative studies in clinical trials, and also to enable and assist research studies using clinical samples from patients enrolled in clinical trials. Emphasis is placed on the pursuit of institutional collaborations, allowing TRL to integrate with other Core laboratories to work closely together.
 
The following will be offered:
 
  • Pre-clinical studies on experimental drug therapies
     
  • Cell proliferation assay and drug cytotoxicity analysis
  • DNA and RNA isolation and quantification
  • Design and optimization of real-time PCR analysis
  • Protein isolation, western blot, and multiplex ELISA assay
 
  • Bio-specimen repository of clinical and population research protocol samples
 
  • Receiving, processing and storing human samples
  • Database management system to centralize information
 
  • General molecular genetic tests and special assays
  • KRAS mutations in colon cancer
  • EGFR mutations and ALK translations in lung cancer
  • P53 mutations in breast cancer
  • NRAS mutations in pancreatic cancer
  • VLH mutations in kidney cancer
 
  • PTEN mutations in brain cancer Circulating Tumor Cell (CTC) enumeration, enrichment and characterization
 

Pricing

Prices and availability vary. PleaseContact Usfor current information.
 
If you are a City of Hope employee, please click here for pricing.

 

 

Translational Research Team

Translational Research Laboratory

Translational Research Laboratory

The Translational Research Laboratory (TRL) at City of Hope is under the direct supervision of Yen Yun, M.D., Ph.D., Associate Director for Translational Research, City of Hope Comprehensive Cancer Center and, Professor and Chair of the Department ofMolecular Pharmacology.
 
The mission of the Translational Research Laboratory (TRL) Core is to facilitate, implement, and support the needs of basic science researchers, clinical researchers, population researchers and clinical science collaborations. Interactions between basic scientists and clinicians are fostered to ensure the inclusion of scientifically sound correlative studies in clinical trials, and also to enable and assist research studies using clinical samples from patients enrolled in clinical trials. Emphasis is placed on the pursuit of institutional collaborations, allowing TRL to integrate with other Core laboratories to work closely together.
 
The following will be offered:
 
  • Pre-clinical studies on experimental drug therapies
     
  • Cell proliferation assay and drug cytotoxicity analysis
  • DNA and RNA isolation and quantification
  • Design and optimization of real-time PCR analysis
  • Protein isolation, western blot, and multiplex ELISA assay
 
  • Bio-specimen repository of clinical and population research protocol samples
 
  • Receiving, processing and storing human samples
  • Database management system to centralize information
 
  • General molecular genetic tests and special assays
  • KRAS mutations in colon cancer
  • EGFR mutations and ALK translations in lung cancer
  • P53 mutations in breast cancer
  • NRAS mutations in pancreatic cancer
  • VLH mutations in kidney cancer
 
  • PTEN mutations in brain cancer Circulating Tumor Cell (CTC) enumeration, enrichment and characterization
 

Pricing

Pricing

Prices and availability vary. PleaseContact Usfor current information.
 
If you are a City of Hope employee, please click here for pricing.

 

 

Translational Research Team

Translational Research Team

Research Shared Services

City of Hope embodies the spirit of scientific collaboration by sharing services and core facilities with colleagues here and around the world.
 

Recognized nationwide for its innovative biomedical research, City of Hope's Beckman Research Institute is home to some of the most tenacious and creative minds in science.
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
Support Our Research
By giving to City of Hope, you support breakthrough discoveries in laboratory research that translate into lifesaving treatments for patients with cancer and other serious diseases.
 
 
 
 
Media Inquiries/Social Media

For media inquiries contact:

Dominique Grignetti
800-888-5323
dgrignetti@coh.org

 

For sponsorships inquiries please contact:

Stefanie Sprester
213-241-7160
ssprester@coh.org

Christine Nassr
213-241-7112
cnassr@coh.org

 
CONNECT WITH US
Facebook  Twitter  YouTube  Blog
 
NEWS & UPDATES
  • Advanced age tops the list among breast cancer risk factor for women. Not far behind is family history and genetics. Two City of Hope researchers delving deep into these issues recently received important grants to advance their studies. Arti Hurria, M.D., director of the Cancer and Aging Research Program, and ...
  • City of Hope is extending the reach of its lifesaving mission well beyond U.S. borders. To that end, three distinguished City of Hope leaders visited China earlier this year to lay the foundation for the institution’s new International Medicine Program. The program is part of City of Hope’s strategi...
  • A hallmark of cancer is that it doesn’t always limit itself to a primary location. It spreads. Breast cancer and lung cancer in particular are prone to spread, or metastasize, to the brain. Often the brain metastasis isn’t discovered until years after the initial diagnosis, just when patients were beginning to ...
  • Blueberries, cinnamon, baikal scullcap, grape seed extract (and grape skin extract), mushrooms, barberry, pomegranates … all contain compounds with the potential to treat, or prevent, cancer. Scientists at City of Hope have found tantalizing evidence of this potential and are determined to explore it to t...
  • Most women who are treated for breast cancer with a mastectomy do not choose to undergo reconstructive surgery. The reasons for this, according to a recent JAMA Surgery study, vary. Nearly half say they do not want any additional surgery, while nearly 34 percent say breast cancer reconstruction simply isn’t imp...
  • The leading risk factor for breast cancer is simply being a woman. The second top risk factor is getting older. Obviously, these two factors cannot be controlled, which is why all women should be aware of their risk and how to minimize those risks. Many risk factors can be mitigated, and simple changes can lead...
  • All women are at some risk of developing the disease in their lifetimes, but breast cancer, like other cancers, has a disproportionate effect on minorities. Although white women have the highest incidence of breast cancer, African-American women have the highest breast cancer death rates of all racial and ethni...
  • First, the good news: HIV infections have dropped dramatically over the past 30 years. Doctors, researchers and health officials have made great strides in preventing and treating the disease, turning what was once a death sentence into, for some, a chronic condition. Now, the reality check: HIV is still a worl...
  • Screening for breast cancer has dramatically increased the number of cancers found before they cause symptoms – catching the disease when it is most treatable and curable. Mammograms, however, are not infallible. It’s important to conduct self-exams, and know the signs and symptoms that should be checked by a h...
  • Rob Darakjian was diagnosed with acute lymphoblastic leukemia at just 19 years old. He began chemotherapy and was in and out of the hospital for four months. After his fourth round of treatment, he received a bone marrow transplantation from an anonymous donor. Today, he’s cancer free.   In his previ...
  • In a single day, former professional triathlete Lisa Birk learned she couldn’t have children and that she had breast cancer. “Where do you go from there?” she asks. For Birk, who swims three miles, runs 10 miles and cycles every day, the answer  ultimately was a decision to take control of her cancer care. Afte...
  • More and more people are surviving cancer, thanks to advanced cancer treatments and screening tools. Today there are nearly 14.5 million cancer survivors in the United States. But in up to 20 percent of cancer patients, the disease ultimately spreads to their brain. Each year, nearly 170,000 new cases of brain ...
  • Cancer cells are masters of survival. Despite excessive damage to their most basic workings and the constant vigilance of the body’s immune system, they manage to persevere. Much of this extraordinary ability to survive falls under the control of proteins bearing the name STAT, short for signal transducer and a...
  • One person receives the breast cancer diagnosis, but the cancer affects the entire family. Couples, in particular, can find the diagnosis and treatment challenging, especially if they have traditional male/female communication styles. “Though every individual is unique, men and women often respond differently d...
  • Here’s a statistic you’ll hear and read frequently over the next month: One in eight women born in the United States will develop breast cancer at some point in her lifetime. Although this statement is accurate, based on breast cancer incidence rates in 2013, it’s often misunderstood. Leslie Bernstein, Ph.D., d...